logo
MedX Announces Extension of Non-Brokered Private Placement

MedX Announces Extension of Non-Brokered Private Placement

National Post06-05-2025
Article content
MISSISSAUGA, Ontario — MedX Health Corp. (' MedX ' or the ' Company ') (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Initial Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025, it has made application to the TSX Venture Exchange for an extension of 30 days to June 6, 2025, within which to effect further closings on this Private Placement. The Initial Closing, effective April 3, 2025, comprised the issuance of 13,500,000 Units (as described in detail in the Company's Press Release dated April 7, 2025) and raised cash proceeds of $945,000. With the extension of the final date for this Placement, it is anticipated that further Closings will take place, for up to a maximum of a further 22,214,285 Units at $0.07 per Unit, to raise up to a further $1,555,000. As previously announced, it is anticipated that, subject to compliance with relevant regulatory provisions, certain Insiders may participate in this Placement at a subsequent Closing, though to not more than 25% of the total funds raised. Funds raised in this Placement will be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes.
Article content
Article content
About MedX Health Corp.:
Article content
MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey. Visit https://medxhealth.com.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Article content
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Former newswire employee convicted of using unpublished press releases for insider trading
Former newswire employee convicted of using unpublished press releases for insider trading

Globe and Mail

time13 minutes ago

  • Globe and Mail

Former newswire employee convicted of using unpublished press releases for insider trading

Toronto-area software developer Harpreet Saini must pay more than $1.4-million in fines and spend several months in jail after pleading guilty to insider trading. The sentence announced by the Ontario Securities Commission on Wednesday ends a years-long investigation into Mr. Saini's use of unpublished corporate press releases to trade securities. The OSC tried the case in the Ontario Court of Justice in order for a jail term to be imposed. Mr. Saini admitted to accessing non-public information between May 2018 and July 2021 when he was an employee of Intrado Corporation, which owned the GlobeNewswire service at the time. GlobeNewswire is among the largest sources of corporate disclosure globally and was most recently acquired in May, 2025, by shareholder services provider Equiniti. It distributes news releases on behalf of thousands of companies based in 90 countries around the world. Mr. Saini traded securities 553 times based on information gleaned from 497 unpublished press releases, according to the OSC, resulting in illicit gains exceeding US$770,000. GlobeNewswire employees in Toronto charged with insider trading and fraud In addition to spending six months less a day in jail, his sentence also requires Mr. Saini to repay roughly $1.15-million in ill-gotten profits plus a $100,000 penalty. Provincial law also imposes a mandatory 25 per cent fine surcharge on that amount, bringing his total financial penalty to $1,436,393.66. During the course of the investigation, OSC staff discovered WhatsApp conversations between Mr. Saini and John Natividad, another former GlobeNewswire programmer, discussing possible price movements in the publicly-listed shares of companies that were preparing to issue news through the service. Court records show the two programmers had found a way around the system maintained by GlobeNewswire to track which employees clicked on news releases before they were published. Employees could hover their cursor over a partial headline to reveal the full title 'without leaving an audit trail,' OSC forensic auditor Anthony Long said in an affidavit. The case against Mr. Natividad, who was charged alongside Mr. Saini in September, 2022, remains ongoing. 'Employees who have access to confidential corporate information have a duty to safeguard that information and not misuse it for their personal benefit,' Bonnie Lysyk,' executive vice president of enforcement at the OSC, said in an statement. 'Insider trading is illegal, and it erodes investor confidence in our markets.' This is one of the first major cases to be concluded under Ms. Lysyk's tenure as the market watchdog's top enforcer. She joined the OSC in October, 2024, after spending a decade as the auditor-general of Ontario. Penalties worth more than $1-million and punishments involving jail time are both rare in securities law violations. In its most recent fiscal year, the Ontario Capital Markets Tribunal – an independent division of the OSC – issued a total of $81.6-million worth of administrative penalties, disgorgement orders and settlement amounts. Sentences involving jail time must be issued by provincial courts as the Tribunal can only impose monetary penalties and ban individuals from trading securities serving as corporate officers or directors. According to the OSC's latest annual report, Ontario courts handed down a total of 57 months worth of jail sentences for matters referred to them by the regulator during its 2023-2024 fiscal year. The OSC also has a long history of struggling to collect the fines it issues. Its current collections rate is just 4.5 per cent, meaning it receives just $4.50 for every $100 in penalties levied.

Toxic substance containing fentanyl, tranquilizers, narcotics circulating in Simcoe-Muskoka region
Toxic substance containing fentanyl, tranquilizers, narcotics circulating in Simcoe-Muskoka region

CTV News

time13 minutes ago

  • CTV News

Toxic substance containing fentanyl, tranquilizers, narcotics circulating in Simcoe-Muskoka region

A toxic substance containing fentanyl, tranquilizers, and other narcotics is now circulating in the Simcoe-Muskoka area. Ontario Provincial Police are sounding the alarm on the illicit substance being referred to as 'Red Down,' reportedly causing extreme sedation and stopping breathing entirely. Several suspected drug-related deaths have been reported in recent days, according to health officials. OPP say they are committed to supporting safe, healthy communities for all Ontarians. 'We sympathize with anyone who has lost a loved one due to an opioid overdose,' provincial police said on Wednesday. Here's what you should know about drug poisoning: The person can't be woken up, and breathing is slow or has stopped. The person is making snoring or gurgling sounds. Fingernails and lips have turned blue, purple, or grey. The body is limp. Pupils are tiny, or eyes are rolled back Further details of the substance are not available but it is believed to be a form of fentanyl and/or fentanyl analogues with animal tranquilizers and/or benzodiazepines added in. If any of these symptoms occur, you can call Crime Stoppers at 1-800-222-8477 (TIPS). Crime Stoppers does not subscribe to call display, and you will remain anonymous. You will not testify in court, and your information may lead to a cash reward of up to $2,000.00.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store